Óskare Capital, the life science and deep tech fund owned by renown investor Bruce Linton and Alpha Blue Ocean, a global investment firm, announced on Thursday the formation of a strategic partnership to collaborate on investment opportunities associated with cannabis plant-based medicines as well as synthetic molecules that target the mammalian endocannabinoid system (ECS).
In a recent press release, both companies acknowledge investment opportunities related to products, infrastructure technologies and services, which will be part of the associated ecosystem for this sector.
